Search research articles
Contact Us
Filters
Showing results (81-90 of 94) with videos related to
Page
of 10
Sort By:
The American Journal of Tropical Medicine and Hygiene
|
March 4, 2020
Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study
Clemente Diaz, Michael Koren, Leyi Lin, et al.
Clinical and Vaccine Immunology : CVI
|
August 24, 2007
Prospective study to determine accuracy of rapid serological assays for diagnosis of acute dengue virus infection in Laos
Stuart D Blacksell, David Bell, James Kelley, et al.
The Journal of Infectious Diseases
|
December 26, 2015
Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection
Hannah E Clapham, Isabel Rodriguez-Barraquer, Andrew S Azman, et al.
The American Journal of Tropical Medicine and Hygiene
|
August 5, 2011
Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants
Veerachai Watanaveeradej, Sriluck Simasathien, Ananda Nisalak, et al.
The New England Journal of Medicine
|
March 3, 2007
Safety and efficacy of a recombinant hepatitis E vaccine
Mrigendra Prasad Shrestha, Robert McNair Scott, Durga Man Joshi, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 29, 2020
Safety and Immunogenicity of an AS03<sub>B</sub>-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study
Leyi Lin, Kirsten E Lyke, Michael Koren, et al.
Plos Pathogens
|
April 23, 2019
Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines
Maria Beatriz Borges, Renato Sergio Marchevsky, Renata Carvalho Pereira, et al.
Vaccine
|
July 12, 2005
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model
J Robert Putnak, Beth-Ann Coller, Gerald Voss, et al.
Plos Neglected Tropical Diseases
|
April 9, 2020
Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques
Michael K McCracken, Gregory D Gromowski, Lindsey S Garver, et al.
NPJ Vaccines
|
April 12, 2023
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop report
Jane M Knisely, Lucas E Buyon, Rebecca Mandt, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 94) with videos related to
Sort By:
Page
of 10
The American Journal of Tropical Medicine and Hygiene
|
March 4, 2020
Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study
Clemente Diaz, Michael Koren, Leyi Lin, et al.
Clinical and Vaccine Immunology : CVI
|
August 24, 2007
Prospective study to determine accuracy of rapid serological assays for diagnosis of acute dengue virus infection in Laos
Stuart D Blacksell, David Bell, James Kelley, et al.
The Journal of Infectious Diseases
|
December 26, 2015
Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection
Hannah E Clapham, Isabel Rodriguez-Barraquer, Andrew S Azman, et al.
The American Journal of Tropical Medicine and Hygiene
|
August 5, 2011
Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants
Veerachai Watanaveeradej, Sriluck Simasathien, Ananda Nisalak, et al.
The New England Journal of Medicine
|
March 3, 2007
Safety and efficacy of a recombinant hepatitis E vaccine
Mrigendra Prasad Shrestha, Robert McNair Scott, Durga Man Joshi, et al.
The American Journal of Tropical Medicine and Hygiene
|
April 29, 2020
Safety and Immunogenicity of an AS03<sub>B</sub>-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study
Leyi Lin, Kirsten E Lyke, Michael Koren, et al.
Plos Pathogens
|
April 23, 2019
Detection of post-vaccination enhanced dengue virus infection in macaques: An improved model for early assessment of dengue vaccines
Maria Beatriz Borges, Renato Sergio Marchevsky, Renata Carvalho Pereira, et al.
Vaccine
|
July 12, 2005
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model
J Robert Putnak, Beth-Ann Coller, Gerald Voss, et al.
Plos Neglected Tropical Diseases
|
April 9, 2020
Route of inoculation and mosquito vector exposure modulate dengue virus replication kinetics and immune responses in rhesus macaques
Michael K McCracken, Gregory D Gromowski, Lindsey S Garver, et al.
NPJ Vaccines
|
April 12, 2023
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop report
Jane M Knisely, Lucas E Buyon, Rebecca Mandt, et al.
Page
of 10